Cyclovax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cyclovax

Quick Facts

  • Active Ingredient: Aciclovir (also known as Acyclovir)
  • Therapeutic Class: Antiviral Agent (Nucleoside Analog)
  • Status: Prescription-only (Rx) in most formulations
  • Primary Action: Inhibits viral DNA synthesis

Cyclovax is a brand-name antiviral medication formulated to treat infections caused by various herpes viruses, most notably the Herpes Simplex Virus (HSV) and the Varicella Zoster Virus (VZV). The active ingredient in Cyclovax is Aciclovir (also commonly spelled Acyclovir).

Aciclovir is classified as a synthetic purine nucleoside analogue, a group of agents that specifically interfere with the life cycle of herpesviruses. This drug is generally available in multiple forms, including oral tablets, creams, and sometimes intravenous solutions, depending on the severity and location of the infection.

Therapeutic Use and Differentiation

Cyclovax is clinically recognized for its targeted efficacy against two major viral infections. Its primary therapeutic uses include the treatment of:

  1. Herpes Zoster (Shingles): It is a standard treatment to reduce the duration and severity of the painful rash associated with shingles, caused by the reactivation of VZV.
  2. Genital Herpes and Cold Sores: The medication helps manage initial and recurrent outbreaks of herpes simplex infections (HSV-1 and HSV-2) on the skin and mucous membranes, helping sores heal faster.

This medication works by selectively inhibiting the viral DNA replication process, thereby stopping the virus from spreading and multiplying within the body’s cells. It is important for patients to note that while Cyclovax can effectively manage outbreaks and symptoms, it is not a cure for herpes infections; the virus remains dormant in the body. Treatment is most effective when initiated as soon as symptoms begin.

Regulatory References

  1. NIH research

What side effects are possible with Cyclovax?

Possible Side Effects and Safety Information

The safety profile of Cyclovax (Aciclovir) is organized by regulatory authorities based on the likelihood of occurrence, classifying documented adverse effects across various System-Organ Classes. This framework distinguishes between commonly observed reactions and specific, rare serious events.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on their documented frequency in regulatory documents. Common reactions are observed in at least 1 in 100 patients and may include headache, dizziness, nausea, vomiting, diarrhea, abdominal pain, fatigue, fever, pruritus, and rash (including photosensitivity). Reactions classified as Uncommon include urticaria and accelerated diffuse hair loss.

Serious Adverse Reactions and System-Organ Class Involvement

Rare and Very Rare serious adverse reactions, as documented in official labeling, include severe neurological events like convulsions, encephalopathy, and confusion; acute renal failure; and hypersensitivity reactions such as anaphylaxis and angioedema. These effects affect systems including the Nervous System, Gastrointestinal System, Renal and Urinary System, and Immune System.

Population-Specific Safety Considerations

The official profile notes that older adults and patients with underlying renal impairment are identified as being at an increased risk of developing reversible neurological adverse effects. Furthermore, official safety constraints advise that adequate hydration should be maintained, particularly when receiving high doses, as a non-dosing measure to support renal function and minimize potential toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes specific manifestations and required actions in the event of Cyclovax (Aciclovir) overexposure. All statements are derived strictly from government regulatory documentation and are not clinical recommendations.

Overdose may present with serious symptoms affecting two main physiological systems:

  • Central Nervous System (CNS): Manifestations include confusion, hallucinations, agitation, tremors, seizures, coma, and encephalopathy.
  • Renal System: Overexposure, particularly from high intravenous doses or repeated oral overdosage, can lead to the precipitation of Aciclovir crystals in the renal tubules. This is characterized by elevated Blood Urea Nitrogen (BUN) and Serum Creatinine, potentially resulting in acute renal failure.

Emergency Actions and Risk Populations

If overdose is suspected or symptomatic, it is mandated that individuals seek immediate medical attention or contact emergency services. Due to the absence of a known specific antidote, treatment is designated as symptomatic and supportive. Supportive measures documented in official prescribing information include ensuring adequate hydration to reduce the risk of crystal formation, and the use of haemodialysis, which significantly enhances drug removal.

Elderly patients and individuals with pre-existing renal impairment are officially noted as high-risk populations due to their increased susceptibility to severe neurological side effects and drug accumulation.

Therapeutic Uses of Cyclovax

What Cyclovax Treats: Main Uses and Benefits

Cyclovax (Aciclovir) is an antiviral treatment primarily directed at managing the symptoms associated with infections caused by the Herpes Simplex Virus (HSV) and the Varicella Zoster Virus (VZV). Its therapeutic goal is to offer support during symptomatic periods. The medication is commonly used across conditions characterized by periods of heightened symptoms including Cold Sores (Herpes Labialis), Genital Herpes, and Shingles (Herpes Zoster).

Core Therapeutic Focus

The treatment is relevant when supportive symptom management is appropriate, particularly for outbreaks that involve both localized lesions and nerve-related discomfort. It helps address symptom clusters that may become intense or disruptive, such as the initial tingling, burning sensation, and formation of blisters and sores. For patients experiencing acute episodes:

“The primary benefit is in assisting with easing the impact of pain and supporting the healing of active lesions to ease the overall symptom burden.”

Cyclovax may assist with promoting the resolution of visible lesions, assisting with maintaining functional stability. It plays a role in managing symptoms related to physical discomfort like burning pain, which contributes to easing the overall symptom burden during acute episodes. It is also applied in clinical settings that involve acute or unstable symptom patterns, such as used to help prevent frequent recurrence for highly recurrent infections.


Quick Fact: Relief for Viral Skin Lesions and Nerve Pain

The medicine is commonly used to help with the acute management of pain and assisting with the healing process of visible sores associated with both Herpes Simplex (HSV) and Varicella Zoster (VZV) viral infections.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Cyclovax?

Eligibility for Cyclovax (Acyclovir/Aciclovir) is determined by regulatory guidelines based on a patient's medical status and age, and is defined by absolute contraindications and necessary restrictions.

Absolute Non-Eligibility (Contraindications)

Classification Rule
Hypersensitivity Cyclovax must not be used by anyone with a known allergy or hypersensitivity to the active substance, aciclovir, or the related drug valaciclovir, or any of the product's inactive ingredients.

Conditional or Restricted Eligibility

Official labeling mandates caution and/or dose modification for certain populations:

  • Renal Impairment: Patients with reduced kidney function must receive a lower, adjusted dose, as the drug is primarily eliminated by the kidneys. Adequate hydration is also necessary, especially during high-dose treatment.
  • Older Adults (Geriatric): Due to the high probability of age-related decrease in kidney function, dose reduction is often required and close monitoring is necessary.
  • Pregnancy and Lactation: Use during pregnancy is conditional; it is permitted only if the potential benefit justifies the potential risk. The drug does pass into breast milk but is often considered safe with caution.
  • Age Groups: While generally approved for adults and adolescents, the safety and effectiveness of certain topical formulations have not been established in young children (e.g., under 12 years).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cyclovax (Acyclovir) interacts with other medicinal products primarily through its elimination pathway, which is dependent on active renal tubular secretion. This competition for secretion can lead to elevated plasma concentrations of Cyclovax, potentially requiring careful management.

Documented Pharmacokinetic Interactions

Coadministration with probenecid is documented to increase the mean half-life and the area under the concentration-time curve (AUC) of Cyclovax. This effect is a result of probenecid reducing the drug's urinary excretion and renal clearance. Similar increases in systemic exposure may occur with the concomitant use of cimetidine or mycophenolate mofetil.

Nephrotoxic Agents

Concomitant use with other medicines known to be nephrotoxic (potentially causing kidney damage) may increase the risk of renal impairment. Healthcare practitioners must closely monitor patients when Cyclovax is used alongside these agents due to the potential for additive effects on the kidneys.

Topical Formulations

For Cyclovax in topical formulations (e.g., cream or ointment), the systemic absorption is minimal. Consequently, clinically significant systemic drug interactions are considered unlikely with these forms.

Population Considerations

Geriatric patients may exhibit higher plasma concentrations of Cyclovax compared to younger adults. This is partly attributed to age-related reductions in renal function, which impacts the clearance of the drug.

Mechanism of Action

How Cyclovax Works: The Mechanism of Action

The active ingredient in Cyclovax, Aciclovir, exerts a highly selective antiviral effect by operating entirely within the boundaries of the viral replication cycle, specifically targeting two key viral enzymes.


Viral Enzyme-Dependent Activation

Aciclovir is an inactive prodrug that requires a mandatory conversion step to become fully effective. This transformation is catalyzed by Viral Thymidine Kinase ( TK), an enzyme produced almost exclusively by herpes viruses ( HSV, VZV) in infected cells. This enzyme-dependent activation ensures the drug's action is highly selective, concentrating the active metabolite (Aciclovir Triphosphate) in the cells where the virus is actively multiplying, resulting in high selectivity for infected cells.


Irreversible DNA Replication Arrest

Once activated, the drug’s active form acts as a counterfeit purine building block, competing with the natural substrate for the Viral DNA Polymerase. When the drug is incorporated into the growing viral DNA chain, it acts as a chain terminator, immediately preventing the synthesis of any further genetic material. This permanent block of viral multiplication is the core mechanism, which results in the arrested multiplication of the virus.


Mechanistic Boundary in Latency

The mechanism’s dependence on active viral enzyme production limits its scope to the active (lytic) phase of infection. Since the Viral TK is not expressed when the virus is dormant (latent) in nerve ganglia, the drug cannot be activated effectively. The mechanism is therefore unable to act upon the dormant viral genome.

Dosage and Administration Information

Cyclovax (Aciclovir) is used according to specific administration protocols outlined in prescribing information. The medication is primarily administered systemically via oral (tablets or suspension) or intravenous (IV) routes, with the chosen route determined by the infection's severity and the clinical setting.


Principles of Administration and Dosage

The standard adult usage pattern distinguishes between acute treatment and long-term suppression. For managing acute episodes, such as shingles (Herpes Zoster), the typical oral regimen is a high dose (e.g., 800 mg) taken five times daily for a fixed duration, usually 7 to 10 days. Treatment is structurally dependent on prompt initiation and is consistent with standard use when started at the earliest signs of infection or within the first 72 hours of symptom onset. In contrast, suppressive therapy for recurrent infections involves a lower dose (e.g., 400 mg) taken twice daily as part of a longer-term plan.

Oral forms may be taken with or without food and are often advised to be taken with a full glass of water. For intravenous use, the lyophilized powder must be properly reconstituted and diluted and then administered by slow infusion over a minimum of one hour.

A critical instruction for all routes is the mandatory dose or interval adjustment for patients with reduced renal function, a modification intended to prevent drug accumulation. This procedural step ensures the regimen aligns with the patient’s clearance capabilities, a requirement that also extends to many older adults.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Cyclovax (Aciclovir)

The research base for Cyclovax (Aciclovir) includes clinical studies, primarily involving Randomized Controlled Trials (RCTs) and various long-term observation studies. The evidence base relates to the clinical evaluation of this medication for use in conditions caused by the Herpes Simplex Virus (HSV) and Varicella Zoster Virus (VZV). This research provides context on how symptoms were measured in groups of patients and does not determine whether an individual will experience a similar outcome.


The Research Foundation for Acute Shingles (Herpes Zoster)

Research exploring how symptoms change over time in people with shingles includes studies relevant to the clinical evaluation of Cyclovax. The studies primarily involved short-term RCTs, where researchers examined patient groups experiencing the acute, painful rash. Outcomes measured included the time necessary for the shingles lesions to crust over and heal, along with the duration and intensity of the associated nerve pain.

Research examined whether the time of administration relates to the reported outcome when initiated very early. Evidence is limited regarding outcomes when treatment initiation occurs substantially later than this narrow window. Additionally, the research provides limited full insight into the complex physiological processes that govern the prevention of Post-Herpetic Neuralgia (PHN).


Clinical Studies for Active Herpes Simplex Outbreaks

The clinical evidence for using Cyclovax to manage conditions characterized by fluctuating or episodic manifestations like genital herpes and cold sores is based on short-term RCTs. Researchers examined outcomes related to physical discomfort, such as the overall time until visible lesions and sores reached complete healing.

Comparative Study Focus: Oral vs. Topical Formulations

Research has also examined different forms of the medication to assess differences in reported outcomes like lesion healing. Research describes differences in the outcomes reported with topical formulations compared to those seen with the oral systemic treatment.


Evidence for Managing and Preventing Recurrence

Cyclovax was evaluated in long-term research focusing on suppression therapy for individuals with frequent or severe recurrent infections. Studies reported long-term measurements of recurrence rates during periods where the medication was observed in studies monitoring responses over defined time intervals. Continuous administration over many months was studied for some patient groups; however, the research focuses on management during active episodes and does not determine the ability to eradicate the latent virus from the body.

Key Studies & References

  1. Acyclovir - StatPearls - NCBI Bookshelf
  2. WHO Guidelines for the Treatment of Genital Herpes Simplex Virus

Frequently Asked Questions (FAQ)

Common questions about Cyclovax (FAQ)


Q: Is it okay to drink alcohol while I'm on a short course of Cyclovax?

Regulatory information does not report a direct chemical interaction between Cyclovax and alcohol. However, official cautions recommend maintaining adequate hydration to support your kidneys while taking this medication. Alcohol can also potentially worsen side effects like dizziness and impact overall fluid levels, so it is important to discuss the use of alcohol with a healthcare provider.


Q: Can children take Cyclovax, and are the side effects different for them?

Yes, official labeling includes specific dosing protocols for pediatric patients based on the type of infection being treated. The FDA label includes warnings regarding potential central nervous system (CNS) adverse reactions in children, particularly if they have underlying reduced kidney function. Monitoring for side effects should be overseen by a healthcare professional.


Q: Does Cyclovax affect birth control pills?

Official drug interaction reports generally do not list hormonal contraceptives, such as birth control pills, as a significant interaction with Cyclovax that would require a change in dosage or method. For comprehensive advice on this topic, it is best to refer to the prescribing information for your specific birth control method.


Q: What should I do if I forget to take a dose of Cyclovax?

Patient information typically suggests taking the missed dose as soon as it is remembered. If it is almost time for your next scheduled dose, skip the one you missed and continue with your regular schedule. Instructions advise against taking a double dose to compensate for a missed one.


Q: Are there any specific foods or supplements I should avoid while on Cyclovax?

The absorption of Cyclovax tablets is generally not affected by food, meaning it can be taken with or without a meal. While no specific foods are usually restricted, official advice emphasizes maintaining adequate hydration. It is generally recommended to discuss any supplements or dietary changes with a healthcare provider.


Q: Can people with kidney issues still use Cyclovax?

Yes, but official guidelines mandate that individuals with reduced kidney function must receive an adjusted dose or interval. This is because Cyclovax is primarily eliminated by the kidneys. Official guidelines recommend close monitoring by a healthcare provider.


Q: Can pregnant women safely use Cyclovax if needed?

The use of Cyclovax during pregnancy is conditional. Official regulatory information states that the drug should only be used if the potential benefit to the mother justifies the potential risk to the fetus. The decision must be made by a healthcare provider.


Q: Will Cyclovax help prevent spreading the virus to others?

For specific infections like genital herpes, certain regimens are approved to help reduce the frequency of outbreaks and, in some cases, reduce the risk of transmission. However, the product label states that continued use of safer sex practices is necessary, as the medication is not a substitute for this.


Q: What are the serious, but less common, side effects of Cyclovax to watch out for?

Serious, though rare, side effects noted in official labeling include severe neurological events like confusion, seizures, or hallucinations, and signs of acute renal failure. Suspected adverse events of this severity require immediate emergency medical attention.


Q: What happens if I accidentally take too much Cyclovax?

Official information on overdosage indicates that symptoms may include extreme agitation, confusion, hallucinations, or a significant decrease in urination. Suspected overdose requires immediate attention from emergency medical services.


Q: Does Cyclovax interact with any common blood pressure medications?

The primary drug interactions for Cyclovax involve other medications that compete for renal clearance or are potentially toxic to the kidneys. There is no single class-wide contraindication for blood pressure medicines, but it is important for a healthcare provider to review all medications being taken.


Q: Does Cyclovax interact with herbal supplements like St. John's wort?

Regulatory documentation does not typically list specific herbal supplements as direct interactions. However, patients should inform their healthcare provider about all supplements they are taking to ensure safety and prevent unknown effects on drug clearance or kidney function.


Q: Does Cyclovax have any impact on liver function tests?

The drug is only minimally processed by the liver, and serious liver injury is rare. However, transient, mild elevations in certain liver enzymes (such as ALT) have been reported, primarily associated with high-dose use of the intravenous formulation.


Q: What happens if I mix Cyclovax with antacids?

Official studies have examined the co-administration of the drug (or its prodrug, valacyclovir) with common antacids, such as those containing aluminum or magnesium. These studies have found that antacids typically do not result in clinically significant changes to the concentration of Cyclovax in the body.


Q: Can a person who is allergic to aspirin take Cyclovax?

The absolute contraindication for Cyclovax is a known allergy or hypersensitivity specifically to its active substance, aciclovir, or the related drug valaciclovir. There is generally no direct contraindication based on an allergy to aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Is it normal to feel a little dizzy right after taking Cyclovax?

Dizziness is documented in official information as a common adverse reaction, which is defined as occurring in at least 1 out of every 100 patients. While the documentation does not specify the exact timing, experiencing dizziness after taking a dose is a known possibility.


Q: Is it possible to develop a resistance to Cyclovax over time?

Developing resistance is a known possibility, as the virus can mutate to become less susceptible to the drug. However, official reports and studies show that the prevalence of drug-resistant virus isolates remains low in patients with healthy immune systems, though the risk is considered higher in those who are immunocompromised.


Q: Why are people often told to drink a lot of water when taking Cyclovax?

The official warning for Cyclovax advises that patients maintain adequate hydration, especially when taking high doses. This recommendation is a precautionary measure intended to support kidney function and minimize the potential for drug crystallization in the kidneys.


Q: Is there a maximum amount of time someone can safely take Cyclovax?

Official guidance includes long-term usage for suppressive therapy to prevent recurrent infections, with studies monitoring patients for periods up to 12 months. However, regulatory labels do not specify an absolute maximum safe duration; the required duration is determined by a healthcare provider on a case-by-case basis.


Q: Can men trying to conceive safely take Cyclovax?

Official guidance indicates that while information is limited, studies involving males taking high doses of the medication have generally not found a significant lowering of sperm production. Paternal exposure is considered unlikely to increase risks to a pregnancy.


Q: Why are the instructions for taking Cyclovax different depending on the infection?

Official prescribing information provides different dosing amounts, frequencies, and total durations for different infections. This difference reflects the varied severity, location, and viral load of conditions such as initial genital herpes, recurrent outbreaks, and shingles.


Q: Can Cyclovax be crushed or split if it's too hard to swallow whole?

Regulatory instructions for standard oral tablets generally direct that they be taken whole. Specific instructions for some related drug forms explicitly warn against crushing or splitting, as this can affect the way the body absorbs the drug and may not be safe.


Q: Is Cyclovax effective against all types of viruses?

No, Cyclovax is a highly selective antiviral agent. Its mechanism requires a viral enzyme, Thymidine Kinase, which is produced primarily by the herpes family of viruses (HSV and VZV). This selectivity means it is not effective against most other types of viruses.


Q: Is there a link between Cyclovax and temporary changes in mood?

Official adverse reaction reports indicate that temporary mental or mood changes are possible, though they are considered rare. These neurological effects may include symptoms like agitation or confusion, and they are more commonly seen in older adults or patients with reduced kidney function.


Q: How quickly does Cyclovax get cleared from the body?

The drug is eliminated primarily by the kidneys. Official pharmacological data indicates that the mean elimination half-life—the time it takes for half of the drug to be cleared—is typically between 2.5 and 3 hours in healthy adults.


Q: Do I need to keep taking Cyclovax even after my symptoms disappear?

For the acute treatment of infections like shingles, regulatory information specifies a fixed total duration of therapy. Official information generally recommends completing the full prescribed duration of therapy, even if symptoms improve quickly.

How should Cyclovax be stored and disposed of?

Storage and Disposal Requirements

Official regulatory documents specify strict storage conditions for Cyclovax (Aciclovir) oral medication. It must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medicine must be protected from moisture and light and should be kept in its original container, which must remain tightly closed. Do not freeze the product.

Handling and Safety

All medicines, including Cyclovax, must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Cyclovax should be disposed of through an authorized drug take-back program. If a take-back program is not available, federal guidelines recommend mixing the medicine with an undesirable substance (such as dirt or coffee grounds) and placing it in a sealed container before discarding it in the household trash. The medication must not be flushed down a toilet or drain unless explicitly directed by the product labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cyclovax found in:

A-Z Index: